Literature DB >> 27460408

New approaches for fibrosis regression in alcoholic cirrhosis.

Wajahat Mehal1,2, Uyen To3.   

Abstract

Liver fibrosis is a dynamic process of fibrinogenesis and fibrinolysis. It is sequelae of recurrent injury and inflammation to the liver. Only recently has there been significant progress in understanding the pathophysiology behind liver fibrosis. This has allowed for the development of identifiable targets for potential therapies. In this article we will discuss the underlying general cellular mechanisms that play a key role in the pathway of fibrinogenesis and fibrinolysis and then focus on the mechanisms that are key in alcohol-induced liver fibrosis. Challenges in formulating potential fibrosis therapies as well as current potential targets for liver fibrosis will be reviewed as well.

Entities:  

Keywords:  Fibrosis; Inflammatory; Liver

Mesh:

Year:  2016        PMID: 27460408      PMCID: PMC5602595          DOI: 10.1007/s12072-016-9752-3

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  56 in total

1.  Association between CD14-159C>T polymorphisms and the risk for alcoholic liver disease: a meta-analysis.

Authors:  Tao Zeng; Cui-Li Zhang; Xiao-Ying Han; Sheng Zhao; Ke-Qin Xie
Journal:  Eur J Gastroenterol Hepatol       Date:  2013-10       Impact factor: 2.566

2.  Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis.

Authors:  Dominique Thabut; Chittaranjan Routray; Gwen Lomberk; Uday Shergill; Kevin Glaser; Robert Huebert; Leena Patel; Tetyana Masyuk; Boris Blechacz; Andrew Vercnocke; Erik Ritman; Richard Ehman; Raul Urrutia; Vijay Shah
Journal:  Hepatology       Date:  2011-06-26       Impact factor: 17.425

3.  Aldehyde dehydrogenase 2 deficiency ameliorates alcoholic fatty liver but worsens liver inflammation and fibrosis in mice.

Authors:  Hyo-Jung Kwon; Young-Suk Won; Ogyi Park; Binxia Chang; Michael J Duryee; Geoffrey E Thiele; Akiko Matsumoto; Surendra Singh; Mohamed A Abdelmegeed; Byoung-Joon Song; Toshihiro Kawamoto; Vasilis Vasiliou; Geoffrey M Thiele; Bin Gao
Journal:  Hepatology       Date:  2014-05-28       Impact factor: 17.425

4.  Genetic dimorphism in superoxide dismutase and susceptibility to alcoholic cirrhosis, hepatocellular carcinoma, and death.

Authors:  Pierre Nahon; Angéla Sutton; Dominique Pessayre; Pierre Rufat; Francoise Degoul; Nathalie Ganne-Carrie; Marianne Ziol; Nathalie Charnaux; Gisèle N'kontchou; Jean-Claude Trinchet; Liliane Gattegno; Michel Beaugrand
Journal:  Clin Gastroenterol Hepatol       Date:  2005-03       Impact factor: 11.382

Review 5.  Exploring anti-TGF-β therapies in cancer and fibrosis.

Authors:  Lukas J A C Hawinkels; Peter Ten Dijke
Journal:  Growth Factors       Date:  2011-06-30       Impact factor: 2.511

Review 6.  Lysyl oxidase: an oxidative enzyme and effector of cell function.

Authors:  H A Lucero; H M Kagan
Journal:  Cell Mol Life Sci       Date:  2006-10       Impact factor: 9.261

Review 7.  Gut-liver axis and sensing microbes.

Authors:  Gyongyi Szabo; Shashi Bala; Jan Petrasek; Arijeet Gattu
Journal:  Dig Dis       Date:  2011-04-27       Impact factor: 2.404

8.  Bone marrow Ly6Chigh monocytes are selectively recruited to injured kidney and differentiate into functionally distinct populations.

Authors:  Shuei Liong Lin; Ana P Castaño; Brian T Nowlin; Mark L Lupher; Jeremy S Duffield
Journal:  J Immunol       Date:  2009-10-28       Impact factor: 5.422

9.  Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis.

Authors:  Bi-Sen Ding; Zhongwei Cao; Raphael Lis; Daniel J Nolan; Peipei Guo; Michael Simons; Mark E Penfold; Koji Shido; Sina Y Rabbany; Shahin Rafii
Journal:  Nature       Date:  2013-11-20       Impact factor: 49.962

Review 10.  Host-microbiome interactions in alcoholic liver disease.

Authors:  Peng Chen; Bernd Schnabl
Journal:  Gut Liver       Date:  2014-05       Impact factor: 4.519

View more
  5 in total

Review 1.  Injury and defective regeneration of the epithelial basement membrane in corneal fibrosis: A paradigm for fibrosis in other organs?

Authors:  Steven E Wilson; Gustavo K Marino; Andre A M Torricelli; Carla S Medeiros
Journal:  Matrix Biol       Date:  2017-06-15       Impact factor: 11.583

2.  CD73-Adenosine A1R Axis Regulates the Activation and Apoptosis of Hepatic Stellate Cells Through the PLC-IP3-Ca2+/DAG-PKC Signaling Pathway.

Authors:  Zhenni Liu; Xue Wu; Qi Wang; Zixuan Li; Xueqi Liu; Xiaodong Sheng; Hong Zhu; Mengda Zhang; Junrui Xu; Xiaowen Feng; Baoming Wu; Xiongwen Lv
Journal:  Front Pharmacol       Date:  2022-06-16       Impact factor: 5.988

3.  Acute decompensation boosts hepatic collagen type III deposition and deteriorates experimental and human cirrhosis.

Authors:  Michael Praktiknjo; Jennifer Lehmann; Mette J Nielsen; Robert Schierwagen; Frank E Uschner; Carsten Meyer; Daniel Thomas; Christian P Strassburg; Flemming Bendtsen; Søren Møller; Aleksander Krag; Morten A Karsdal; Diana J Leeming; Jonel Trebicka
Journal:  Hepatol Commun       Date:  2018-01-18

4.  Collagen type IV remodelling gender-specifically predicts mortality in decompensated cirrhosis.

Authors:  Jennifer Lehmann; Michael Praktiknjo; Mette Juul Nielsen; Robert Schierwagen; Carsten Meyer; Daniel Thomas; Francesco Violi; Christian P Strassburg; Flemming Bendtsen; Søren Møller; Aleksander Krag; Morten Asser Karsdal; Diana Julie Leeming; Jonel Trebicka
Journal:  Liver Int       Date:  2019-03-07       Impact factor: 5.828

5.  Hepatic injuries resulting from chronic alcohol abuse identified by forensics.

Authors:  Dragoş Valentin Crauciuc; Cristinel Ionel Stan; Laura Adriana Rîşcanu; Octavian Ion Predescu; Diana Bulgaru-Iliescu
Journal:  Rom J Morphol Embryol       Date:  2021 Jul-Sep       Impact factor: 0.833

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.